Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.5 CHF | -0.56% | +4.64% | +5.46% |
04-26 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
04-24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
Evolution of the average Target Price on Novartis AG
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Novartis AG
JEFFERIES | Peter Welford |
BMO Capital | |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
alphavalue | Abhishek Raval |
JPMORGAN | Richard Vosser |
BARCLAYS | Emily Field |
UBS | Matthew Weston |
BERENBERG | Kerry Holford |
DZ BANK | Elmar Kraus |
Kepler Capital Markets | |
Societe Generale | |
Redburn | |
Stifel Nicolaus | |
BNP Paribas | |
MORGAN STANLEY | Mark Purcell |
Barrington Research | |
Credit Suisse | |
International Strategy & Investment Group | |
Morningstar | |
ODDO BHF | |
GOLDMAN SACHS | Keyur Parekh |
DA Davidson | |
Zacks Equity Research | |
Bank of America Securities/Merrill Lynch | |
BERNSTEIN RESEARCH | Wimal Kapadia |
Kepler Cheuvreux | |
Wolfe Research | |
AltaCorp Capital | |
DEUTSCHE BANK | Emmanuel Papadakis |
HSBC | |
Exane BNP Paribas | |
Bryan, Garnier & Co. | |
Berenberg Bank | |
Deutsche Bank Securities | |
Moody's Investors Service | |
Dundee | |
Exane BNP | |
Bernstein | |
Argus | |
Cowen | |
BRYAN GARNIER | Eric Le Berrigaud |
LIBERUM CAPITAL | Graham Doyle |
BANK OF AMERICA (BOFA) | Graham Parry |
EPS Revisions
- Stock Market
- Equities
- NOVN Stock
- Consensus Novartis AG